The Marzetti Company (MZTI) gains on deep earnings analysis
The Marzetti Company (MZTI) gained after a deeper look at fiscal Q4 results showed an EPS beat, record gross profit, and margin expansion despite softer revenue. This analysis goes beyond the headline to examine brand momentum, segment trends, guidance, and the key questions shaping the stock’s next move.
The Marzetti Company (MZTI) rose 2.62% after fiscal Q4 results showed adjusted EPS of $1.46, ahead of the $1.42 estimate, even as revenue missed consensus at $465 million. Investors focused on record gross profit, a 12th straight quarter of margin expansion, and strong brand momentum in Bachan’s and Texas Roadhouse rolls, which outweighed softer reported sales. The stock’s move suggests the market is rewarding profitability and execution more than top-line growth, though guidance and Cyclospora-related pressure remain key watch items.
The Marzetti Company (MZTI) delivered a fiscal Q4 adjusted EPS beat, posting $1.46 against a $1.42 estimate. Revenue came in at $465 million, below the $0.48B consensus, yet shares gained 2.62% to $118.7922 in regular trading on Aug. 25, 2026. The market rewarded record gross profit, another quarter of margin expansion, and strong brand momentum despite softer reported sales.
Key Takeaways
Adjusted EPS reached $1.46, beating the $1.42 estimate. Revenue of $465 million missed the $0.48B consensus.
Reported sales fell 2.2%, but adjusted sales grew 40 basis points after excluding discontinued temporary supply agreement revenue.
Retail sales rose 0.9%. Bachan’s added $15.4 million of incremental sales, while Texas Roadhouse rolls grew 28.1%.
Gross margin expanded for the 12th straight quarter. Adjusted operating income increased 17.5%.
Fiscal 2027 guidance includes a 23% tax rate, $90 million of capital spending, moderate input inflation, and a 250-basis-point first-quarter Cyclospora headwind.
Analyst consensus remains Hold, with 3 Buy ratings, 9 Hold ratings, and 1 Sell rating. Post-earnings questions focused on margins, Bachan’s, and Cyclospora.
The headline MZTI earnings result was mixed but profitable. Adjusted diluted EPS rose to $1.46 from the prior-year period and exceeded the $1.42 consensus. That result also improved on the May quarter’s $1.47 actual against a $1.57 estimate, marking a cleaner earnings performance after recent estimate misses.
Revenue presented a less polished picture. Consolidated net sales declined 2.2% to $465 million. However, the comparison included the end of a temporary supply agreement that reduced reported growth by 260 basis points. Excluding those noncore sales, adjusted net sales increased 40 basis points. In plain English, the top line had an accounting comparison problem as well as genuine volume pressure.
Retail was the stronger segment. Net sales increased 0.9%, including the two-month contribution from Bachan’s. The company said lower club-channel sales and the comparison with last year’s Texas Roadhouse dinner-roll pipeline build weighed on the quarter. Still, the underlying brand data remained constructive.
Bachan’s scanner sales rose 8.7% for the quarter ending June 30, while total distribution points increased 16.6%. Texas Roadhouse rolls grew 28.1% during the quarter and generated $58 million of sales over the 52-week period, up 76% from the prior year. Combined with sister brand Schubert’s, the rolls held a 61.7% share. New York Bakery sales rose 2.8%, taking a 45.5% category share after a 220-basis-point gain.
Foodservice was steadier than the reported consolidated figure suggested. Excluding the temporary supply agreement, adjusted sales and pounds shipped were nearly unchanged. Gains from leading national chain restaurant accounts offset lower sales to other chains and weaker branded foodservice products. For the fiscal year ended June 30, the segment schedule listed $927.054 million in Foodservice revenue and $1.002769B in Retail Segment revenue.
Profitability was the quarter’s strongest feature. Gross profit increased $7.9 million, or 7.4%, to $114 million. Reported gross margin expanded 22 basis points, while adjusted gross margin expanded 160 basis points. The company credited productivity work across procurement, manufacturing, distribution, network changes, and value engineering.
Reported operating income rose 48.2%, helped by an $18.5 million gain from selling the closed Milpitas, California manufacturing facility. Adjusted operating income increased 17.5%, or $7.8 million, after removing acquisition costs and restructuring items. SG&A increased $12.3 million, mostly because of Bachan’s transaction and integration costs, but adjusted SG&A rose only $100,000.
The quality of cash generation also supports the investment case. Fiscal 2026 operating cash flow reached a record $283.8 million, up 8.5%. The company ended the year with slightly less than $200 million of long-term debt, a roughly 4.8% effective interest rate, and completed $36.3 million of share buybacks.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
MZTI shares gained 2.62% to $118.7922 during regular trading on Aug. 25. Volume reached 560,028 shares versus an average of 328,760, giving the move more weight than a thinly traded bounce. The reaction shows that investors placed greater value on earnings quality and margin control than on the revenue miss.
The analyst consensus remains Hold. Three analysts carry Buy ratings, nine carry Hold ratings, and one carries a Sell rating. That balance leaves the stock with a cautious Street backdrop, even as the quarterly EPS beat and 12th consecutive quarter of gross-margin expansion improve the operating narrative.
The post-earnings analyst reaction centered on whether margin gains can continue through soybean-oil inflation, how quickly Bachan’s can scale, and whether the Cyclospora issue represents a temporary disruption. Stephens, Loop Capital, and D.A. Davidson all pressed management on those points. The focus was practical rather than promotional, which fits a company still balancing dependable cash returns against uneven volume.
Management Commentary: Growth, Margins, and Guidance
CEO David Ciesinski framed fiscal 2026 as a year of operational progress. The company reported record full-year net sales, gross profit, and operating income. It also marked four straight years of record net sales and gross profit, plus three straight years of record operating income.
“the 3 simple pillars of our growth plan: 1, accelerate core business growth. 2, simplify our supply chain to reduce our cost and grow our margins. And, 3, expand our core with focused M&A and strategic licensing.” - David Ciesinski, CEO, MZTI earnings call
That strategy puts Bachan’s at the center of the fiscal 2027 growth story. Ciesinski said the company will support the brand with marketing, advertising, and two innovations: Bachan’s wing sauce and Japanese mayo. The wing sauce will be produced at Marzetti’s Horse Cave, Kentucky facility. New products from New York Bakery, single-serve Chick-fil-A avocado lime ranch dressing, and the return of Schubert’s sausage rolls add further retail support.
“At this point, we estimate that the outbreak will result in a net sales headwind of approximately 250 basis points in our fiscal first quarter.” - David Ciesinski, CEO, MZTI earnings call
CFO Tom Pigott supplied the financial guardrails. Marzetti expects moderate aggregate input inflation in fiscal 2027 and plans to offset it through pricing and cost savings. Pricing takes effect in the fiscal first quarter. The company also forecasts $90 million of capital expenditures and a 23% tax rate.
“We estimate our tax rate for fiscal 27 to be 23%.” - Tom Pigott, CFO, MZTI earnings call
Pigott also stressed the balance between investment and shareholder returns. The company raised its quarterly dividend 5% and maintained a 63-year streak of annual dividend increases. That combination of $283.8 million in operating cash flow, less than $200 million of long-term debt, and ongoing buybacks gives Marzetti room to fund growth without abandoning capital returns.
“We continue to invest to support the growth of our business while returning funds to shareholders.” - Tom Pigott, CFO, MZTI earnings call
Stephens analyst Jim Salera went straight at the central margin concern: soybean oil inflation. He noted that soybean oil was up nearly 40% year to date while Marzetti continued to deliver gross-margin outperformance.
“I know you’re probably sick of me asking about soybean oil, but you keep delivering gross margin outperformance, and that’s against the backdrop of soybean oil up nearly 40% year to date.” - Jim Salera, Stephens
Ciesinski defended the procurement team’s execution and pointed to hedging as a reason the company protected the latest period. He also tied the fiscal 2027 margin plan to pricing, productivity, and Bachan’s accretion. The exchange exposed the main risk: Marzetti has built a strong margin record, but commodity protection must keep working while volume remains soft.
“we were able to protect ourselves in the most recent period with hedges.” - David Ciesinski, CEO, MZTI earnings call
Loop Capital analyst Alton Stump pressed management on the Cyclospora outbreak and asked for comparisons with prior events. Management’s response pointed toward a pattern closer to the 2018 outbreak than the more severe 2022 episode. The company still quantified a 250-basis-point first-quarter sales headwind across both Retail and Foodservice, so the near-term impact is material even if the disruption remains temporary.
D.A. Davidson analyst Matt Curtis focused on the timing of fiscal 2027 margin improvement. Management described roughly 100 basis points of consolidated gross-margin growth, split between Bachan’s accretion and commodity risk management and cost savings. That answer supports a broader margin story, but it also makes execution timing important because the revenue outlook includes both new products and a first-quarter health-related headwind.
Bottom Line
The Marzetti Company earnings analysis points to a business winning on margins, cash flow, and selected brands while still fighting uneven volume. For investors, the $1.46 EPS beat, Bachan’s expansion, and disciplined cost program strengthen the case for fiscal 2027, while the revenue miss and 250-basis-point Cyclospora headwind keep the Hold consensus understandable.
+Did The Marzetti Company (MZTI) beat earnings in its latest quarter?
Yes. The Marzetti Company reported adjusted EPS of $1.46, topping the $1.42 consensus estimate. Revenue was $465 million, which missed the $0.48 billion expectation.
+Why did MZTI stock rise after earnings even though revenue missed?
Shares rose because investors focused on profitability, not just sales. Gross profit hit a record level, adjusted gross margin expanded for the 12th straight quarter, and adjusted operating income increased 17.5%.
+How did Bachan’s and Texas Roadhouse rolls perform for Marzetti (MZTI)?
Bachan’s added $15.4 million of incremental sales and its scanner sales rose 8.7% in the quarter. Texas Roadhouse rolls grew 28.1% during the quarter and generated $58 million of sales over the last 52 weeks, up 76% year over year.
+What is The Marzetti Company’s outlook after fiscal Q4 earnings?
Management guided to a 23% tax rate, $90 million of capital spending, moderate input inflation, and a 250-basis-point Cyclospora headwind in the first quarter of fiscal 2027. The analyst consensus remains Hold, with 3 Buy ratings, 9 Hold ratings, and 1 Sell rating.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
▌The Full Report
Want the full picture on MZTI?
The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.
